Drugs / HC034S
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07813468 | Sep 2026 → Jun 2027 expected | — | HC Biopharma Inc. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HC034S | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07813468 ↗ |
| Route | Intravenous | “Administer intravenously by infusion pump” NCT07813468 ↗ |